Back to 
XTX Topco Ltd
XTX Topco Ltd
MBRX1 quarters
Position history for XTX Topco Ltd's holdings in MOLECULIN BIOTECH INC
Yes. XTX Topco holds 22,942 shares of MBRX (Moleculin Biotech), worth $64,008, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$64,008
Current Shares
22,942
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of MBRX: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, VANGUARD FIDUCIARY TRUST CO, JANE STREET GROUP, LLC